ASCML
MDT icon

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Medtronic MDT Stock Holding History

ADKINS SEALE CAPITAL MANAGEMENT LLC’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.4K Hold
210
– – 0.01% 184
2026
Q1 		$18.2K Hold
210
– – 0.02% 171
2025
Q4 		$20.2K Buy
+210
New +$20.4K 0.02% 172

Other funds holding MDT

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return

ADKINS SEALE CAPITAL MANAGEMENT LLC's MDT Position: Q2 2026 in Review

ADKINS SEALE CAPITAL MANAGEMENT LLC held its Medtronic (MDT) position steady in Q2 2026 at 210 shares worth $16.4K. The position accounts for 0.01% of the portfolio, ranked #184.

ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in MDT in Q4 2025 and has held it in 3 quarters since. The position peaked at $20.2K in Q4 2025. 1,239 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • ADKINS SEALE CAPITAL MANAGEMENT LLC held 210 shares of Medtronic worth $16.4K as of Q2 2026.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.01% of ADKINS SEALE CAPITAL MANAGEMENT LLC's portfolio in Q2 2026, its #184 holding.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC first reported a position in Medtronic in Q4 2025 and has held it in 3 quarters since.
  • ADKINS SEALE CAPITAL MANAGEMENT LLC's Medtronic position peaked at $20.2K in Q4 2025.
  • 1,239 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on ADKINS SEALE CAPITAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 5 Aug 2026.